Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Altimmune, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 159 | 3 | 183 | +27 |
| Shares | 41.5M | 35.4K | 55.1M | +13.6M (+32.8%) |
| Value | $156.4M | $134.1K | $198.8M | +$42.6M (+27.2%) |
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (48)
Institutions that held Altimmune, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (21)
Institutions that held Altimmune, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Asset Management, L.P. | 476,926 | $1.80M |
| Simplex Trading, LLC | 213,709 | $805.0K |
| Gsa Capital Partners LLP | 116,770 | $440.0K |
| Macquarie Group Ltd | 100,000 | $377.0K |
| DLD Asset Management, LP | 50,000 | $188.5K |
| Sig Brokerage, LP | 34,502 | $130.1K |
| Kraematon Investment Advisors, Inc | 17,435 | $65.7K |
| Fortis Capital Management LLC | 16,606 | $62.6K |
| Walleye Trading LLC | 14,759 | $55.6K |
| Cambridge Investment Research Advisors, Inc. | 12,532 | $47.0K |
| Quarry LP | 5,019 | $18.9K |
| HighTower Advisors, LLC | 4,909 | $18.5K |
| FNY Investment Advisers, LLC | 5,000 | $18.0K |
| Groupe la Francaise | 1,200 | $3.87K |
| NBC Securities, Inc. | 1,000 | $3.77K |
| Global Retirement Partners, LLC | 1,000 | $3.77K |
| Hollencrest Capital Management | 770 | $2.90K |
| Bessemer Group Inc | 660 | $2.00K |
| IFP Advisors, Inc | 200 | $754 |
| Ameritas Advisory Services, LLC | 200 | $754 |
| Federated Hermes, Inc. | 75 | $283 |
Not filed for Q4 2025 yet (3)
Institutions that held Altimmune, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wolverine Trading, LLC | 21,820 | $82.7K |
| Point72 (DIFC) Ltd | 8,143 | $30.7K |
| Point72 Europe (London) LLP | 5,484 | $20.7K |